We are live on ! Find out more
ARA

American Renal Associates Holdings, Inc
ARA

Delisted

ARA was delisted on the 25th of January, 2021.

59 hedge funds and large institutions have $460M invested in American Renal Associates Holdings, Inc in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 18 increasing their positions, 21 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

140% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 5

2% more funds holding

Funds holding: 5859 (+1)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

14% less repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 21

19% less capital invested

Capital invested by funds: $571M → $460M (-$111M)

Holders
59
Holders Change
+1
Holders Change %
+1.72%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
18
Reduced
21
Closed
5
Calls
$246K
Puts
Net Calls
+$246K
Net Calls Change
+$246K
Name Holding Trade Value Shares
Change
Change in
Stake
CP
1
Centerbridge Partners
New York
$297M
Fidelity Investments
2
Fidelity Investments
Massachusetts
$67.3M +$9.99M +500,624 +14%
TCM
3
TimesSquare Capital Management
New York
$20.4M +$828K +41,500 +4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$15.7M +$1.92M +96,196 +12%
Goldman Sachs
5
Goldman Sachs
New York
$12M -$63.9K -3,201 -0.4%
Franklin Resources
6
Franklin Resources
California
$9.19M -$2.36M -118,484 -18%
BlackRock
7
BlackRock
New York
$9.19M +$10.8M +543,127 +53,828%
AAM
8
AMI Asset Management
California
$7.55M +$1.35M +67,725 +18%
American Century Companies
9
American Century Companies
Missouri
$3.76M -$1.1M -55,231 -20%
State Street
10
State Street
Massachusetts
$2.34M -$674K -33,794 -20%
Northern Trust
11
Northern Trust
Illinois
$1.82M +$49.6K +2,487 +2%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$1.31M +$43.5K +2,180 +3%
AIM
13
Alambic Investment Management
California
$950K +$355K +17,797 +46%
AP
14
AHL Partners
United Kingdom
$882K +$1.04M +52,252 New
ECM
15
Endurant Capital Management
California
$776K +$917K +45,978 New
Morgan Stanley
16
Morgan Stanley
New York
$681K +$119K +5,968 +17%
Barclays
17
Barclays
United Kingdom
$657K +$451K +22,611 +139%
Charles Schwab
18
Charles Schwab
California
$656K +$51.2K +2,565 +7%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$614K -$30.3K -1,518 -4%
Acadian Asset Management
20
Acadian Asset Management
Massachusetts
$588K +$695K +34,831 New
Bank of America
21
Bank of America
North Carolina
$504K +$106K +5,296 +22%
GAM
22
Gotham Asset Management
New York
$499K -$154K -7,713 -21%
SO
23
STRS Ohio
Ohio
$494K
TCIM
24
TIAA CREF Investment Management
New York
$384K -$34.9K -1,750 -7%
Deutsche Bank
25
Deutsche Bank
Germany
$382K -$53.4K -2,679 -11%

ARA Hedge Fund Activity: Q1 2017 in Review

59 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in American Renal Associates Holdings, Inc (ARA) for Q1 2017, worth a combined $460M — down 19% from $571M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new ARA positions and 5 closed out — a net gain of 7 holders — while 18 added to existing stakes and 21 trimmed.

The largest buyer was BlackRock, adding an estimated $10.8M. The largest seller was Penn Capital Management, exiting entirely with an estimated $3.49M sold.

  • 59 institutional investors held American Renal Associates Holdings, Inc (ARA) as of Q1 2017, up from 58 in Q4 2016.
  • Funds reported $460M of American Renal Associates Holdings, Inc stock for Q1 2017, down 19% quarter-over-quarter.
  • 12 funds opened new American Renal Associates Holdings, Inc positions in Q1 2017 and 5 closed out, a net change of +7 holders.
  • The largest American Renal Associates Holdings, Inc buyer in Q1 2017 was BlackRock, an estimated $10.8M added.
  • The largest American Renal Associates Holdings, Inc seller in Q1 2017 was Penn Capital Management, an estimated $3.49M sold.

Based on aggregated 13F filings for Q1 2017.